Intralytix proudly supports the advancement of phage-based science and applications through corporate sponsorships and collaborations.

Intralytix has supported several scientific conferences, including:

• 1^st International Symposium on Advances in Phage Therapeutics, Braga, Portugal, 2025
• Viruses of Microbes (VoM) 2024, Cairns, Australia
• American Society for Microbiology (ASM), Bacteriophage Division 2024
• American Society for Microbiology (ASM), Bacteriophage Division 2023
• Viruses of Microbes (VoM) 2023, Tbilisi, Georgia
• 10^th Microbiome R&D & Business Collaboration Forum USA, 2022
• 9^th Microbiome R&D and Business Collaboration Forum USA, 2022
• 5^th Probiotics congress USA, 2022
• 3^rd Skin Microbiome and Cosmeceuticals Congress USA, 2022
• 10^th Microbiome R&D and Business Collaboration Forum: Europe, 2022
• 7^th Probiotics & Prebiotics Congress: Europe, 2022
• 4^th Skin Microbiome & Cosmeceuticals Congress: Europe, 2022
• Viruses of Microbes (VoM), 2022, Guimarães, Portugal
• Evergreen Phage Conference, 2019
• American Society for Microbiology (Bacteriophage Division), 2019
• Centennial Celebration of Bacteriophage Research, Institute Pasteur, 2017

Intralytix also supports/has supported* small phage-related R&D projects in the U.S. and internationally (e.g., France, Russia, Denmark, Philippines).

For inquires on sponsorships or phage R&D project opportunities, contact us at: info@intralytix.com.

*Funding levels depend on extent of project with indirect cost rates strictly limited to a maximum of 30%.